Methods for preparing indazole compounds

Details for Australian Patent Application No. 2005300241 (hide)

Owner Pfizer Inc.

Inventors Haddach, Aubrey; Srirangam, Jayaram Katsuri; Zook, Scott Edward; Ouellette, Michael Allen; Dagnino, Raymond Jr.; Mitchell, Mark Bryan; Yu, Shu; Saenz, James Edward; Babu, Srinivasan

Agent Shelston IP

Pub. Number AU-A-2005300241

PCT Pub. Number WO2006/048761

Priority 60/624,719 02.11.04 US; 60/624,801 14.12.04 US

Filing date 21 October 2005

Wipo publication date 11 May 2006

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/048761 Priority application(s): WO2006/048761

13 September 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Aug 2007

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300248-Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal

2005300239-N-Hydroxy - 4-{5-[4-(5-isoproyl-2-methyl-1,3-thiazol4-yl)phenoxy] pentoxy} benzamidine 2 methansulfonic acid salt